001). Biliary leakage is the most common complication after OCJ; no complication was experienced in the LCJ group. LCJ is a feasible and safe option for patients undergoing choledochojejunostomy. LCJ is a feasible and safe option for patients undergoing choledochojejunostomy.Schizophrenia is a chronic mental disorder with marked symptoms of hallucination, delusion, and impaired cognitive behaviors. Although multidimensional factors have been associated with the development of schizophrenia, the principal cause of the disorder remains debatable. Microbiome involvement in the etiology of schizophrenia has been widely researched due to the advancement in sequencing technologies. This review describes the contribution of the gut microbiome in the development of schizophrenia that is facilitated by the gut-brain axis. The gut microbiota is connected to the gut-brain axis via several pathways and mechanisms, that are discussed in this review. The role of the oral microbiota, probiotics and prebiotics in shaping the gut microbiota are also highlighted. Lastly, future perspectives for microbiome research in schizophrenia are addressed. To investigate if phacoemulsification is an aerosol generating procedure in a live patient environment. New Hayesbank Ophthalmology Services, Kent, UK. In vivo experimental human eyes study METHODS We measured aerosol particle counts sized ≤0.3µm, >0.3 ≤0.5µm, >0.5 ≤1µm, >1 ≤2.5µm, >2.5 ≤5µm, and >5 ≤10µm during elective phacoemulsification surgery of 25 eyes. The baseline particle count in our operating theatre was measured on 2 separate days to assess for fluctuation. Then we measured 5 readings each during pre-phacoemulsification, and phacoemulsification of all eyes. We also measured the difference in aerosol generation during pre-phacoemulsification and phacoemulsification with the use of the mobile laminar air flow (LAF) machine. Lastly, we measured aerosol generation during phacoemulsification with the use of HPMC (2% hydroxypropyl methylcellulose). There was no significant difference in measurement of aerosol between the baseline measurements on both days and between each patienteld.The management of malignant glaucoma involves either anterior vitrectomy with zonulectomy and iridectomy or 3-port core pars plana vitrectomy (PPV) by retinal surgeons. The proposed modification can be performed with reasonable success rates. In this technique, synechiolysis and anterior chamber irrigation is performed through a limbal incision, and a single-port 23- or 25-gauge vitrector is introduced through PPV superotemporally to perform anterior vitrectomy and central posterior capsulotomy in pseudophakic eyes. The same procedure can be performed after cataract surgery in phakic eyes. Vitrectomy is continued until anterior chamber deepens, ensuring a conduit between anterior and posterior chambers through the posterior capsulotomy alone, bypassing the need for a posterior iridectomy/zonulectomy. In a series on 9 eyes, all achieved optimization of anterior chamber depth with IOP normalization in 8 of 9 eyes without showing any signs of recurrence at a mean follow-up of 8.6 months. To evaluate the agreement between different parameters obtained with two swept-source optical coherence tomography (SS-OCT)-based biometers and one Scheimpflug camera with partial coherence interferometry (PCI). Oftalvist, Spain. Prospective case series. Biometry was performed in 49 eyes using 3 optical biometers ANTERION SS-OCT, IOLMaster 700 SS-OCT, and Pentacam AXL PCI. Keratometry (K), J0 and J45 vectors, anterior chamber depth (ACD), central corneal thickness (CCT), white-to-white (WTW), lens thickness (LT), and axial length (AL) were measured with each device. https://www.selleckchem.com/products/epibrassinolide.html Bland-Altman analysis was applied. There were no statistically significant differences for K1, K2, J0 and J45 between the 3 devices (p>0.9). In contrast, there was a statistically significant difference in the ACD, CCT, WTW, LT, and AL between the biometers (p<0.001). Specifically, there was a statistically significant difference between ACD, CCT, and WTW values for all-pairwise comparisons. IOLMaster showed the shortest ACD value and ANTERION showed the largest ACD. IOLMaster showed the highest CCT and Pentacam showed the lowest CCT. IOLMaster showed the largest WTW and Pentacam showed the shortest WTW. The LT measured with IOLMaster was thicker than that measured with ANTERION. There was a statistically significant difference in the AL between IOLMaster and Pentacam, with a shorter AL measured with IOLMaster (p<0.001), but no differences were found between ANTERION and IOLMaster (p=0.599) and between ANTERION and Pentacam (p=0.054). Mean differences and the limits of agreement obtained in all-pairwise comparisons of the different parameters should be judged clinically to consider the interchangeability of these devices. Mean differences and the limits of agreement obtained in all-pairwise comparisons of the different parameters should be judged clinically to consider the interchangeability of these devices. To investigate the potential additive effect of systemic supplemental oxygen administered during accelerated corneal crosslinking (CXL) for progressive keratoconus (KCN). Department of ophthalmology at an academic center DESIGN Randomized Clinical Trial METHODS This study includes eyes with progressive KCN ranodmized to three different CXL protocols. The first group (OA-CXL) included 19 eyes that underwent an accelerated CXL protocol (9 mW/ cm2 for 10 minutes) while receiving systemic oxygen at a rate of 5 liters/minute for 10 minutes. The second group consisted of 14 eyes undergoing the same accelerated CXL protocol without supplemental oxygen therapy (A-CXL). The third group (C-CXL) was comprised of 14 eyes undergoing conventional CXL according to the Dresden protocol. All subjects were followed for at least six months. Visual acuity, keratometry and corneal biomechanical parameters including corneal hysteresis (CH) and corneal resistance factor (CRF) were measured preoperatively and 6 months postoperat 56.03 ± 5.28 D in the C-CXL group (P=0.58), which reached 53.58 ± 3.24, 54.59 ± 4.65 and 55.87 ± 4.73 D at six months in the three study groups, respectively (P= 0.115). Mean CRF was increased significantly only in the OA-CXL group from a baseline value of 6.32 ± 2.12 to 7.38 ± 1.88 mmHg at 6 months (P=0.009) CONCLUSION This study suggests superior efficacy of an accelerated CXL protocol coupled with systemic oxygen supplementation as compared to the accelerated CXL protocol and the conventional protocolin eyes with progressive KCN. . In addition to greater reduction in K max as the primary outcome, improvement in corneal biomechanics was also observed at 6 months.